Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Biotechnology

Background:

• Receptor tyrosine kinases (RTKs) are crucial for cell functions but their abnormal activation drives cancer.
• Targeting RTKs is a key strategy in cancer therapy.
• Current antibody-based therapies face limitations like cost and immunogenicity.

Purpose of the Study:

• To review the application of phage display for developing peptide ligands targeting RTKs.
• To discuss the potential of these peptide ligands in tumor-targeted cancer therapy.

Main Methods:

• Phage display technology for rapid selection of peptide ligands.
• Identification and characterization of peptide ligands for specific RTKs.
• Evaluation of peptide targeting capabilities in vitro and in vivo.

Main Results:

• Phage display effectively identifies high-affinity peptide ligands for RTKs.
• These peptide ligands demonstrate potential for targeting tumor cells.
• Peptides offer advantages over antibodies, including lower cost and reduced immunogenicity.

Conclusions:

• Phage display is a powerful tool for developing novel peptide-based therapeutics for RTK-driven cancers.
• Peptide ligands represent a promising and practical approach for targeted cancer therapy.
• Further development of phage-derived peptides could lead to new treatment strategies.